Showing 291-300 of 300 results for "".
- Icahn to Push for Changes at Bausch Health After Disclosing Stakehttps://modernod.com/news/icahn-to-push-for-changes-at-bausch-health-after-disclosing-stake/2478869/Activist investor Carl Icahn disclosed in a regulatory filing that he has accumulated a 7.8% stake in Bausch Health, making him the largest single shareholder in the company. According to the filing, Icahn believes Bausch shares are “undervalued,” and that he plans to “engage in
- GSK, CureVac Partner to Develop mRNA Vaccines for COVID-19 Variantshttps://modernod.com/news/gsk-curevac-partner-to-develop-mrna-vaccines-for-covid-19-variants/2478831/GlaxoSmithKline entered into a new collaboration with CureVac to develop a multi-valent mRNA candidate vaccine to address multiple emerging variants of COVID-19, the companies announced Wednesday. “We believe that next-generation vaccines will be crucial in the continued fight against COVID
- Insurers Taking ‘Wait and See’ Approach to COVID-19 in 2021 ACA Exchange Rates: Expertshttps://modernod.com/news/insurers-taking-wait-and-see-approach-to-covid-19-in-2021-aca-exchange-rates-experts/2478454/Most insurers on the Affordable Care Act’s (ACA’s) insurance exchanges aren’t factoring COVID-19 into their 2021 rates or believe the pandemic will have a negligible effect, according to several experts, FierceHealthcare
- Synairgen’s Inhaled Interferon Beta Cuts Chance of Developing Severe COVID-19 Diseasehttps://modernod.com/news/synairgens-inhaled-interferon-beta-cuts-chance-of-developing-severe-covid-19-disease/2478043/Synairgen announced Monday that its inhaled formulation of interferon beta, dubbed SNG001, significantly reduced the chance of developing severe disease compared to placebo in hospitalized COVID-19 patients. Chief study investigator Tom Wilkinson remarked “the results confirm our belief tha
- Market Scope: Premium IOL Volume Faces Challenges in Rebounding Post-COVIDhttps://modernod.com/news/market-scope-premium-iol-volume-faces-challenges-in-rebounding-post-covid/2477871/Results from Part 1 of Market Scope’s “COVID-19 US Practice Impact Survey” reveal that nearly 41 percent of surgeons expect a decrease in premium IOL conversion once COVID-19 subsides. These surgeons expect an average decrease of 34 percent, and most respondents believe that financial
- Mystery Inflammatory Syndrome In Kids And Teens Likely Linked To COVID-19https://modernod.com/news/mystery-inflammatory-syndrome-in-kids-and-teens-likely-linked-to-covid-19/2477722/Sixty-four children and teens in New York State are suspected of having a mysterious inflammatory syndrome that is believed to be linked to COVID-19, the New York Department of Health said in an alert issued Wednesday, as
- Kala Pharmaceuticals Resubmits NDA for Eysuvis for Dry Eye Diseasehttps://modernod.com/news/kala-pharmaceuticals-resubmits-nda-for-eysuvis-for-dry-eye-disease/2477696/Kala Pharmaceuticals announced that it has resubmitted its new drug application (NDA) to the FDA for Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25%, a product candidate for the short-term treatment of the signs and symptoms of dry eye disease. Kala believes this application will be c
- Gymnast Laurie Hernandez Partners With Alcon for New “Eye Can, Eye Will” Campaignhttps://modernod.com/news/gymnast-laurie-hernandez-partners-with-alcon-for-new-eye-can-eye-will-campaign/2476665/Alcon is teaming up with gold- and silver-medal winning gymnast Laurie Hernandez on the new “Eye Can, Eye Will” campaign, which is based on Laurie’s belief that clear, comfortable vision with DAILIES TOTAL1 contact lenses have helped her maintain the focus and enthusiasm needed to get to the top
- Novartis Exits Antibacterial, Antiviral Researchhttps://modernod.com/news/novartis-exits-antibacterial-antiviral-research/2480028/Novartis will close its antibacterial and antiviral research operations in Emeryville, California as part of CEO Vas Narasimhan’s plans to narrow the drugmaker’s R&D focus. Spokesman Ryan McBride said while “there is a commercial market for these medicines…we do not believe
- Ophthalmologists Issue Eye Safety Warning Ahead of Fireworkshttps://modernod.com/news/ophthalmologists-issue-eye-safety-warning-ahead-of-fireworks-severy-year-about-10000-people-are-rushed-to-the-emergency-department-for-fireworks-injuries-ophthalmologists-physicians-who-s/2480108/Every year, about 10,000 people are rushed to the emergency department for fireworks injuries. Ophthalmologists treat thousands of patients who suffer a range of fireworks-related injuries, from cuts and bruises to damaged corneas, retinas, and ruptured eyeballs. Many people believe that consumer
- Previous
- Next